Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.64 0.00 (-0.78%)
As of: Sep 30, 2026 · 1:44 PM EDT

Biodexa Pharmaceuticals Plc (BDRX) EBIT (2013 - 2026)

Updated

Biodexa Pharmaceuticals (BDRX) recorded EBIT of -$5.65 million in the quarter ended Jun 30, 2026, compared with -$5.36 million a year earlier.

Analysis

Biodexa Pharmaceuticals Plc (BDRX) EBIT (2013 - 2026) Analysis & Trends

On a TTM basis, Biodexa Pharmaceuticals' EBIT came in at -$21.77 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it was -$11.4 million.

  • Across earlier years, EBIT came in at -$11.76 million in the year ended Dec 31, 2024, -$9.97 million in the year ended Dec 31, 2023, -$11.05 million in the year ended Dec 31, 2022 and -$9.63 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBIT since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.65 Mn
Dec 31, 2025 -5.34 Mn
Jun 30, 2025 -5.36 Mn
Dec 31, 2024 -5.42 Mn
Jun 30, 2023 -5.31 Mn
Dec 31, 2022 -4.43 Mn
Dec 31, 2020 -30.42 Mn
Dec 31, 2019 -14.55 Mn
Dec 31, 2018 -15.20 Mn
Dec 31, 2017 -6.19 Mn
Dec 31, 2016 -20.48 Mn
Dec 31, 2015 -26.67 Mn
Dec 31, 2014 -15.35 Mn
Dec 31, 2013 -7.28 Mn
API Access

Biodexa Pharmaceuticals Plc EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=BDRX&period=max&api_key=YOUR_API_KEY